CRISPR-based gene editing shows promise in treating rare for

About 79% of clinical trial participants experienced measurable improvement after receiving experimental, CRISPR-based gene editing that is designed to fix a rare form of blindness, according to a paper published in the New England Journal of Medicine.

Related Keywords

Boston , Massachusetts , United States , Oregon , Ann Arbor , Michigan , Florida , University Of Pennsylvania , Pennsylvania , Philadelphia , Baisong Mei , Mark Pennesi , Tomass Aleman , Scheie Eye Institute , Bascom Palmer Eye Institute In Miami , University Of Pennsylvania Scheie Eye Institute , Oregon Health Science University , Kellogg Eye Center , Casey Eye Institute , New England Journal , Oregon Health , Science University , Leber Congenital Amaurosis , Eye Institute , Editas Medicine , Mass Eye , Eric Pierce , Scheie Eye , Editas Medicine Chief Medical Officer , Bascom Palmer Eye Institute ,